Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease

Factors Predicting Erythropoietin Resistance among Maintenance Hemodialysis Patients

(2012) Salman Mallick et al.   BLOOD PURIFICATION

The New FDA Labeling for ESA--Implications for Patients and Providers

(2012) B. J. Manns et al.   Clinical Journal of the American Society of Nephrology

An expert opinion on the current treatment of anemia in patients with kidney disease

(2012) Francesco Locatelli et al.   EXPERT OPINION ON PHARMACOTHERAPY

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

(2011) John J.V. McMurray et al.   AMERICAN HEART JOURNAL

Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa

(2011) Hicham Skali et al.   CIRCULATION

What Caused Excess Strokes in Patients Randomized to Darbepoetin in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)?

(2011) Wolfgang C. Winkelmayer   CIRCULATION

Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp(R) Therapy (TREAT) Study

(2010) F. Locatelli et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

(2010) Scott D. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hyporesponsiveness to Erythropoietin: Causes and Management

(2009) James Elliott et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment

(2009) Lynda A. Szczech et al.   KIDNEY INTERNATIONAL

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

(2009) Marc A. Pfeffer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes

(2008) Lynda A. Szczech et al.   KIDNEY INTERNATIONAL

The Normal Hematocrit Study — Follow-up

(2008) Anatole Besarab et al.   NEW ENGLAND JOURNAL OF MEDICINE